ScholarIQanswers from OpenAlex

Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial

PaperCitations, authors & open-access status

Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial have?

ScholarIQcitation count

Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial has 1 citations in the OpenAlex counts ScholarIQ stores.

When was Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial published?

ScholarIQyear

Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial has 2026 year in the ScholarIQ index.

What is the open-access status of Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial?

ScholarIQoa status

Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial has hybrid oa status in the ScholarIQ index.

What is the DOI of Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial?

ScholarIQdoi

The DOI for Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial is on the source record.

What is the PMID of Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial?

ScholarIQpmid

The PMID for Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial is on the source record.

What is the OpenAlex record for Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial?

ScholarIQopenalex

The OpenAlex for Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial